Johnson & Johnson (JNJ) Net Margin (2009 - 2026)
Johnson & Johnson (JNJ) posted Net Margin of 21.76% for Q1 2026, up 4.46% sequentially from 20.83% in Q4 2025, and down 2848.0% YoY from 0.79% in Q1 2025.
Johnson & Johnson (JNJ) Net Margin (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 17 years of Net Margin data on file, last reported at 21.76% in Q1 2026.
- Quarterly Net Margin fell 2848.0% year-over-year to 21.76% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.83% (up 952.0% YoY) and the FY2023 annual result came in at 25.63%, up 2367.0% from the prior year.
- Net Margin improved to 21.76% in Q1 2026 per JNJ's latest filing, from 20.83% in the prior quarter.
- The five-year high for Net Margin was 101.72% in Q4 2023, with the low at 1.08% in Q3 2023.
- Average Net Margin over 4 years is 19.06%, with a median of 2.91% recorded in 2022.
- Year-over-year, Net Margin jumped 10098 bps in 2023 and slumped 2848 bps in 2026.
- Johnson & Johnson's Net Margin stood at 0.74% in 2022, then slumped by 152 bps to 0.39% in 2023, then jumped by 5469 bps to 20.83% in 2025, then gained by 4 bps to 21.76% in 2026.
- Business Quant data shows JNJ's Net Margin at 21.76% in Q1 2026, 20.83% in Q4 2025, and 21.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 37.36% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 21.76% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 4.65% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 329.02% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -0.56% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 12.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 21.76% |
| Dec 28, 2025 | 20.83% |
| Sep 28, 2025 | 21.47% |
| Jun 29, 2025 | 23.32% |
| Mar 30, 2025 | 50.24% |
| Dec 31, 2023 | -0.39% |
| Oct 1, 2023 | 101.72% |
| Jul 2, 2023 | -1.08% |
| Apr 2, 2023 | 2.02% |
| Jan 1, 2023 | 1.47% |
| Oct 2, 2022 | 0.74% |
| Jul 3, 2022 | 2.73% |
| Apr 3, 2022 | 2.91% |
| Oct 3, 2021 | 15.71% |
| Jul 4, 2021 | 26.93% |
| Apr 4, 2021 | 27.76% |
| Jan 3, 2021 | 7.73% |
| Sep 27, 2020 | 16.86% |
| Jun 28, 2020 | 19.78% |
| Mar 29, 2020 | 28.01% |